T1	Participants 35 89	patients with newly diagnosed type 1 diabetes mellitus
T2	Participants 122 163	18 patients with Type 1 diabetes mellitus
T3	Participants 165 304	All were participating in the Canadian-European randomized placebo-controlled cyclosporin trial in newly diagnosed Type 1 diabetic patients
